Product
99mTccAbVCAM1-5
1 clinical trial
2 indications
Indication
Cardiovascular DiseasesIndication
AtherosclerosisClinical trial
Phase I Study, Prospective, Monocentric, Uncontrolled, Non-randomized, Open, Interventional. First Human Administration of an Inflammation Tracer (99mTc-cAbVCAM1-5) Using the Scintigraphy in Healthy Volunteers and Asymptomatic Patients.Status: Active (not recruiting), Estimated PCD: 2023-05-01